International Clinical Trial: A Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism, Excretion of [14C]AZD4954 and the Absolute Bioavailability of AZD4954

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07812077) titled 'A Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism, Excretion of [14C]AZD4954 and the Absolute Bioavailability of AZD4954' on Sept. 4.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: AstraZeneca

Condition: Healthy Participants

Intervention: Drug: [14C]AZD4954 Oral Solution Drug: AZD4954 film-coated tablet

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: October 19, 2026

Target Sample Size: 16

To know more, visit http...